<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:13:25.4289672+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-MMR-T-UNOPS-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Tuberculosis - Myanmar (01-Jan-2011-31-Dec-2012)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Myanmar, Tuberculosis, United Nations Office for Project Services (UNOPS)</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<other-identifier ref="MMR-T-UNOPSP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2011-01-01" />
		<activity-date type="2" iso-date="2011-01-01" />
		<activity-date type="3" iso-date="2012-12-31" />
		<activity-date type="4" iso-date="2012-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Allan, NFAMBA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>allan.nfamba@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="MM" percentage="100">
			<narrative xml:lang="en">Myanmar</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12263" percentage="100">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="67b5c16e-3102-4c35-8129-cf41a6d8cfbd">
			<transaction-type code="2" />
			<transaction-date iso-date="2011-01-01" />
			<value currency="USD" value-date="2011-01-01">24621616.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f0a558f3-bf26-4339-ae23-da2149bf4ff4">
			<transaction-type code="3" />
			<transaction-date iso-date="2010-12-13" />
			<value currency="USD" value-date="2010-12-13">6618574.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0be7bd8b-1ce8-446e-a77c-fc1b69eb25cf">
			<transaction-type code="3" />
			<transaction-date iso-date="2010-12-20" />
			<value currency="USD" value-date="2010-12-20">567466.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ff51459c-870b-408f-9c44-97dfac29c07f">
			<transaction-type code="3" />
			<transaction-date iso-date="2012-12-17" />
			<value currency="USD" value-date="2012-12-17">8024084.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c989c70d-970e-4e54-a00b-84ef6c84a940">
			<transaction-type code="3" />
			<transaction-date iso-date="2012-03-16" />
			<value currency="USD" value-date="2012-03-16">8380518.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f7b418bd-d167-4c3d-ac29-60a79460a69f">
			<transaction-type code="3" />
			<transaction-date iso-date="2012-09-14" />
			<value currency="USD" value-date="2012-09-14">1030974.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-MMR-T-UNOPS-5</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis - Myanmar (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Myanmar, Tuberculosis, United Nations Office for Project Services (UNOPS)This program has the following goals: End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035) 50% reduction of TB incidence compared with 2015 baseline by 2025. The objectives of this program are: Expand TB services as part of Universal Health Coverage and strengthen partnerships.  Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations.  Achieve a faster decline in TB burden through an accelerated multisectoral TB response</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<other-identifier ref="MMR-T-UNOPSP05" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<activity-date type="4" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Allan, NFAMBA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>allan.nfamba@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="MM" percentage="100">
			<narrative xml:lang="en">Myanmar</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="27">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="6">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="67">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="27">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector governance and planning -&gt; Policy and planning for national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Remuneration &amp; deployment of existing/new staff (excluding community health workers)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Civil registration and vital statistics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Key Populations (MDR-TB) - Children</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="27">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy (TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="22">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">17671130.62</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">39590608.22</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">25083415.12</value>
		</budget>
		<transaction ref="702bc583-88ba-4e2d-a9a6-c40b97ce05e6">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-3689613.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2430aece-60c8-46d2-a7c2-d91810f71758">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-23" />
			<value currency="USD" value-date="2025-06-23">-11339305.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="740642b5-0c0f-4c4d-9f88-374b8e484588">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-15" />
			<value currency="USD" value-date="2022-12-15">27153897.30</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3cfb80cc-7ee2-494c-8217-b84f5e922fbd">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-03" />
			<value currency="USD" value-date="2023-07-03">26555777.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="770a4fa7-2e35-466b-8901-f6022035fc79">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-01-09" />
			<value currency="USD" value-date="2021-01-09">45509632.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="62f7dddf-afb4-4c17-91e7-fa8b72ad1765">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-08-23" />
			<value currency="USD" value-date="2023-08-23">14958360.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c2d79c3c-30d8-4e1d-b4e6-db49142db7d1">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-07-07" />
			<value currency="USD" value-date="2021-07-07">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b4fbf93c-fc72-44b2-9c41-b4582d734bba">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-08-23" />
			<value currency="USD" value-date="2023-08-23">-15018360.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a8fa6a27-c877-4ac9-b2c4-19a10d68aaf2">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-23" />
			<value currency="USD" value-date="2023-07-23">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5110cbbf-4c1a-4d13-8cf5-ad138aaf6a0a">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-03" />
			<value currency="USD" value-date="2023-07-03">-9168893.30</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="efe35f7e-fced-4af7-ab89-09d9afdc2d66">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-30" />
			<value currency="USD" value-date="2024-09-30">-26460.16</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3cd1454a-e511-4c30-8f58-31acc5477d6a">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-15" />
			<value currency="USD" value-date="2022-12-15">-11901088.38</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="758586de-06a9-49f8-8494-6a9c5c1d7d0a">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">-26460.16</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d7602a1b-4425-4609-8648-a14c7b490cda">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-3689613.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fa273170-4146-43a4-9d92-f91e0252c996">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-01-13" />
			<value currency="USD" value-date="2021-01-13">11365561.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9acfc009-7fbd-4609-915b-9fee611d88b7">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-07" />
			<value currency="USD" value-date="2021-10-07">7066183.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="78b35318-6338-4db8-8db5-b152f7b211df">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-01-29" />
			<value currency="USD" value-date="2024-01-29">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e0f0a215-f59d-40f3-936e-4d6fc7d37ce6">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-07-15" />
			<value currency="USD" value-date="2021-07-15">4455819.62</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4c934347-bc0f-465f-9050-1c5cfc7efc4b">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-28" />
			<value currency="USD" value-date="2023-03-28">6270265.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="21afdff1-dd2f-4c03-9c20-102a01dc3c62">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-12-16" />
			<value currency="USD" value-date="2021-12-16">6815438.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ae4b6d64-4f4b-4353-b845-d3bbd1318602">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-05" />
			<value currency="USD" value-date="2023-10-05">3619055.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1d36ea56-da88-4e4a-9ba4-39c43c1a3cb7">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-07-06" />
			<value currency="USD" value-date="2023-07-06">11537417.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="29e11aa4-9146-4afe-81ce-b9f82872e6e8">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-21" />
			<value currency="USD" value-date="2023-03-21">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7bb9bed2-13cf-424b-8549-97aec49d88b1">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-06-23" />
			<value currency="USD" value-date="2022-06-23">3905542.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5c7f0faa-81f1-492f-b5d3-dc87900145be">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-19" />
			<value currency="USD" value-date="2022-12-19">11714739.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP05.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for MMR-T-UNOPSP05</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="27538" />
					<actual value="25907" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="13754" />
					<actual value="5125" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="27563" />
					<actual value="21267" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="13781" />
					<actual value="10833" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="13753" />
					<actual value="4038" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="13782" />
					<actual value="10434" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="13769" />
					<actual value="11567" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="13769" />
					<actual value="14340" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="27507" />
					<actual value="9163" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="67951" />
					<actual value="61534" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="69755" />
					<actual value="60474" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="69755" />
					<actual value="46612" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="139510" />
					<actual value="107086" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="71446" />
					<actual value="32088" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="71447" />
					<actual value="33713" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="142893" />
					<actual value="65801" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="67951" />
					<actual value="64420" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="135902" />
					<actual value="125954" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="32510" />
					<actual value="37099" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="16287" />
					<actual value="14800" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="32357" />
					<actual value="39682" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="16179" />
					<actual value="19968" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="16178" />
					<actual value="19714" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="16255" />
					<actual value="19414" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="32574" />
					<actual value="27112" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="16255" />
					<actual value="17685" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="16287" />
					<actual value="12312" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="2.50" />
					<actual value="2.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.27" />
					<actual value="3.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="2.27" />
					<actual value="2.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2.39" />
					<actual value="5.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="2.39" />
					<actual value="1.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2.40" />
					<actual value="4.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.30" />
					<actual value="2.80" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="2.51" />
					<actual value="3.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="2.51" />
					<actual value="1.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="11290" />
					<actual value="9236" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="9990" />
					<actual value="6822" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="19979" />
					<actual value="11387" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="10530" />
					<actual value="7631" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="10531" />
					<actual value="9337" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="11291" />
					<actual value="9285" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="22581" />
					<actual value="18521" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="9989" />
					<actual value="4565" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="21061" />
					<actual value="16968" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="87.99" />
					<actual value="64.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="84.99" />
					<actual value="57.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="65.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="88.00" />
					<actual value="62.50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="85.00" />
					<actual value="54.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="75.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="87.99" />
					<actual value="60.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="70.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="85.00" />
					<actual value="52.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2174" />
					<actual value="1269" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2519" />
					<actual value="1273" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="2519" />
					<actual value="1355" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="1920" />
					<actual value="453" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1920" />
					<actual value="979" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="5038" />
					<actual value="2628" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="2174" />
					<actual value="1421" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="3840" />
					<actual value="1432" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="4348" />
					<actual value="2690" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases (all forms) notified among prisoners</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="1555" />
					<actual value="76" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="1514" />
					<actual value="243" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="1230" />
					<actual value="27" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3029" />
					<actual value="776" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1555" />
					<actual value="134" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="3110" />
					<actual value="210" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1515" />
					<actual value="533" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="2461" />
					<actual value="35" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1231" />
					<actual value="8" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in contact with TB patients who began preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="5100" />
					<actual value="59" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="13072" />
					<actual value="2261" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="10200" />
					<actual value="250" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="6536" />
					<actual value="661" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="15970" />
					<actual value="5506" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="7985" />
					<actual value="3256" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="7985" />
					<actual value="2250" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="5100" />
					<actual value="191" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="6536" />
					<actual value="1600" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="4000.2" />
					<actual value="2310" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="3456" />
					<actual value="1295" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4786.2" />
					<actual value="2525" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1728" />
					<actual value="767" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="1728" />
					<actual value="528" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="2393.05" />
					<actual value="1289" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="2000.08" />
					<actual value="1157" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2393.05" />
					<actual value="1236" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2000.08" />
					<actual value="1153" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="96.00" />
					<actual value="87.70" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="96.00" />
					<actual value="87.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="96.00" />
					<actual value="89.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="96.00" />
					<actual value="88.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="97.00" />
					<actual value="92.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="97.00" />
					<actual value="94.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="97.00" />
					<actual value="89.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="96.00" />
					<actual value="84.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="96.00" />
					<actual value="87.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="85.03" />
					<actual value="41.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="80.00" />
					<actual value="32.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="80.00" />
					<actual value="32.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="52.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="43.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="48.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.00" />
					<actual value="39.40" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.03" />
					<actual value="37.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="80.00" />
					<actual value="32.40" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for MMR-T-UNOPSP05</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="77.27" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="82.00" />
					<actual value="75.79" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="81.00" />
					<actual value="75.79" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="258.42" />
					<actual value="119.73" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="241.63" />
					<actual value="219" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="250.15" />
					<actual value="219" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="55.87" />
					<actual value="17.31" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="66.15" />
					<actual value="20.69" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="77.53" />
					<actual value="20.69" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="89.25" />
					<actual value="33.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="92.47" />
					<actual value="46.04" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.94" />
					<actual value="46.04" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="118205" />
					<actual value="63617" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="128608" />
					<actual value="60939" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="125559" />
					<actual value="60939" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for MMR-T-UNOPSP05</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="26" />
					<actual value="59" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="20" />
					<actual value="80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="23" />
					<actual value="80" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="290" />
					<actual value="360" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="275" />
					<actual value="475" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="261" />
					<actual value="475" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="4.90" />
					<actual value="4.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4.90" />
					<actual value="4.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4.90" />
					<actual value="4.10" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-MMR-T-UNOPS-4</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis - Myanmar (01-Jan-2018-31-Dec-2020)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Myanmar, Tuberculosis, United Nations Office for Project Services (UNOPS)This program has the following goals: To End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035). The objectives of this program are: To accelerate the decline in the prevalence of drug-sensitive and drug-resistant TB.  To fully integrate TB prevention and care in Universal Health Coverage.  To enhance the prevention of TB, particularly for high-risk populations</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<other-identifier ref="MMR-T-UNOPSP04" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2018-01-01" />
		<activity-date type="2" iso-date="2018-01-01" />
		<activity-date type="3" iso-date="2020-12-31" />
		<activity-date type="4" iso-date="2020-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Allan, NFAMBA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>allan.nfamba@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="MM" percentage="100">
			<narrative xml:lang="en">Myanmar</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="25">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="16">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="59">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk mitigation for disease programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="20">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Other program management intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Financial management systems -&gt; Public financial management (country or donor harmonized) systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; National product selection, registration and quality monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Other procurement supply chain management intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Retention and scale-up of health workers, including for community health workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="10">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Removing human rights and gender related barriers to MDR-TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="19">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Other TB care and prevention intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2018-01-01">32570199.56</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2018-01-01" />
			<period-end iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-01-01">18079229.74</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2018-01-01">26631942.68</value>
		</budget>
		<transaction ref="56f7c33a-7f6e-4026-af42-fd06fc3fada7">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-07-22" />
			<value currency="USD" value-date="2019-07-22">32975668.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4f6fadc1-84b9-4883-89ee-d81e93b72e50">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-05-15" />
			<value currency="USD" value-date="2020-05-15">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1e93bf50-8ae4-42f3-9c30-4a3927340402">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-07-26" />
			<value currency="USD" value-date="2022-07-26">-1972883.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="671123d2-749c-4070-963a-32cd21c2d0ba">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-03-27" />
			<value currency="USD" value-date="2018-03-27">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ced00f3c-dd0e-4751-8d22-0dc6299bf780">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-05-29" />
			<value currency="USD" value-date="2019-05-29">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d806742e-12b8-44b5-87b4-4698e6ea5801">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-12-19" />
			<value currency="USD" value-date="2017-12-19">36982043.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9f8f70a7-ae41-4725-b7b7-64674c135591">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-07-06" />
			<value currency="USD" value-date="2020-07-06">-8218902.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2dc6620d-7d09-4701-856a-97ee94ba525a">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-17" />
			<value currency="USD" value-date="2023-07-17">-598.55</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7458855e-2c87-44db-ac3e-3d5e75910c93">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-17" />
			<value currency="USD" value-date="2023-07-17">-833.79</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="07bd1a5e-9c4c-468d-a79c-b7dac09e6f14">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-07-06" />
			<value currency="USD" value-date="2020-07-06">19355078.42</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ae1f3841-c35c-4f17-90e9-a9768ff8cecd">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-07-22" />
			<value currency="USD" value-date="2019-07-22">-9502561.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9a3581e7-d100-48ae-bf5b-788f66d1d714">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-07-01" />
			<value currency="USD" value-date="2023-07-01">-598.55</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d6f88664-c404-425a-b403-792d0ee4db77">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-08-07" />
			<value currency="USD" value-date="2018-08-07">4045192.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f6a39bd7-df42-481e-b2a8-f393a34b5853">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-07-23" />
			<value currency="USD" value-date="2019-07-23">8551912.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="82ec8191-60f0-414a-8cc8-cab385616569">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-10-23" />
			<value currency="USD" value-date="2018-10-23">4452161.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e7a00c02-8da1-41c8-bf7a-3d837146bc60">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-10-05" />
			<value currency="USD" value-date="2018-10-05">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e7b92030-9661-44d5-b3d9-64d96b69da1e">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-01-14" />
			<value currency="USD" value-date="2020-01-14">3565229.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b92cf569-3187-4103-9590-984d3f3d666f">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-27" />
			<value currency="USD" value-date="2020-11-27">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f31aa8c6-f021-4cca-acfe-f00e97e8520d">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-10" />
			<value currency="USD" value-date="2019-10-10">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="91701f6d-f3a7-46ee-961a-9781f89afcfd">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-01-15" />
			<value currency="USD" value-date="2019-01-15">5755252.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b0122a37-e8eb-4468-9444-f54108fd8562">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-05-08" />
			<value currency="USD" value-date="2018-05-08">3670258.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7c1409c1-8725-47d9-83b1-3bc7a5a6fd47">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-04-02" />
			<value currency="USD" value-date="2019-04-02">4169807.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e577dc70-0c85-4322-b795-6ad03ba5bea9">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-01" />
			<value currency="USD" value-date="2019-10-01">6638278.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="05c89e1e-4235-4d3f-a83e-83145b822c2e">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-04-02" />
			<value currency="USD" value-date="2020-04-02">6001347.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9b3c66cd-1589-4fb5-9705-b458de69aa65">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-21" />
			<value currency="USD" value-date="2017-12-21">5386812.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="735c327e-b0c1-4c7b-a09b-5a403f608348">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-07-15" />
			<value currency="USD" value-date="2020-07-15">8415898.42</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a6847779-eff1-48f9-8603-07a60032135d">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-10-02" />
			<value currency="USD" value-date="2020-10-02">8966297.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="afc13552-9c0f-49bf-907a-26597b5d90f7">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-07-01" />
			<value currency="USD" value-date="2023-07-01">-833.79</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP04.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for MMR-T-UNOPSP04</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="90.00" />
					<actual value="87.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.00" />
					<actual value="87.90" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="90.00" />
					<actual value="87.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.00" />
					<actual value="53949" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.00" />
					<actual value="87.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="88.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="96.00" />
					<actual value="97.20" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="96.00" />
					<actual value="97.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="96.00" />
					<actual value="97.50" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="96.00" />
					<actual value="97.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="94.00" />
					<actual value="96.40" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="94.00" />
					<actual value="96.20" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="18236" />
					<actual value="8813" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="17032" />
					<actual value="12825" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="17032" />
					<actual value="14449" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="7512" />
					<actual value="5000" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="18236" />
					<actual value="11095" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="7512" />
					<actual value="5627" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="74802" />
					<actual value="45169" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="71899" />
					<actual value="67812" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="79312" />
					<actual value="69840" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="74802" />
					<actual value="55794" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="79312" />
					<actual value="64069" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="71898" />
					<actual value="63527" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="7459" />
					<actual value="4152" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="12976" />
					<actual value="10341" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="7459" />
					<actual value="6611" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="12977" />
					<actual value="10335" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="14091" />
					<actual value="8631" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="14092" />
					<actual value="7852" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="73.90" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="80.00" />
					<actual value="66.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="80.00" />
					<actual value="57.80" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="90.00" />
					<actual value="65.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="85.00" />
					<actual value="74.80" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="85.00" />
					<actual value="62.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="14768" />
					<actual value="13131" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="14577" />
					<actual value="10021" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="16061" />
					<actual value="8500" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="12558" />
					<actual value="11685" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="13632" />
					<actual value="11540" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="13605" />
					<actual value="14009" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases (all forms) notified among prisoners</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="660" />
					<actual value="261" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="660" />
					<actual value="1047" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="660" />
					<actual value="368" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="308" />
					<actual value="350" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="660" />
					<actual value="560" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="308" />
					<actual value="656" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70.00" />
					<actual value="59.60" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="60.00" />
					<actual value="36.10" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="65.00" />
					<actual value="47.70" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="60.00" />
					<actual value="48.10" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="70.00" />
					<actual value="57.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="65.00" />
					<actual value="50.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="360" />
					<actual value="277" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="530" />
					<actual value="1048" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="420" />
					<actual value="713" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="530" />
					<actual value="1074" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="420" />
					<actual value="505" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="360" />
					<actual value="216" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="3.00" />
					<actual value="1.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1.53" />
					<actual value="2.40" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="1.80" />
					<actual value="2.20" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="1.81" />
					<actual value="2.90" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1.53" />
					<actual value="2.90" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="3.00" />
					<actual value="1.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="98.10" />
					<actual value="98.10" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="100.00" />
					<actual value="98.40" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="98.10" />
					<actual value="98.20" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="98.10" />
					<actual value="98.30" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="98.07" />
					<actual value="81.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100.00" />
					<actual value="98.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="90.00" />
					<actual value="96.90" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.00" />
					<actual value="95.10" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.00" />
					<actual value="91.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="96.90" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.00" />
					<actual value="85.20" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="90.00" />
					<actual value="92.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="1825" />
					<actual value="1302" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="1962" />
					<actual value="1430" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1966" />
					<actual value="1290" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="1962" />
					<actual value="1276" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="1826" />
					<actual value="1279" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1967" />
					<actual value="1067" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="2226" />
					<actual value="1537" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="2452" />
					<actual value="1773" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="2453" />
					<actual value="1706" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="2226" />
					<actual value="1668" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="2313" />
					<actual value="1325" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2313" />
					<actual value="983" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="50.00" />
					<actual value="17.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="50.00" />
					<actual value="32.30" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="50.00" />
					<actual value="20.60" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="50.00" />
					<actual value="24.10" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="50.00" />
					<actual value="13.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="50.00" />
					<actual value="24.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="95.00" />
					<actual value="96.90" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="95.00" />
					<actual value="97.00" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="99.00" />
					<actual value="94.90" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="98.00" />
					<actual value="98.30" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="99.00" />
					<actual value="97.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="98.00" />
					<actual value="97.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="100.00" />
					<actual value="99.70" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="100.00" />
					<actual value="92.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="100.00" />
					<actual value="99.70" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for MMR-T-UNOPSP04</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="90.00" />
					<actual value="110500" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="90.00" />
					<actual value="116494" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="81.00" />
					<actual value="79.90" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="81.99" />
					<actual value="78.85" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="81.98" />
					<actual value="79.52" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="292" />
					<actual value="247" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="259" />
					<actual value="252.11" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="267" />
					<actual value="248" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="84.00" />
					<actual value="76.41" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="86.00" />
					<actual value="77.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="54.50" />
					<actual value="39.99" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="58.37" />
					<actual value="39.57" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="60.39" />
					<actual value="23.08" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for MMR-T-UNOPSP04</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="45" />
					<actual value="51" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="43" />
					<actual value="39" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="41" />
					<actual value="36" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="406" />
					<actual value="358" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="339" />
					<actual value="339" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="322" />
					<actual value="322" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB prevalence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="386" />
					<actual value="436" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-MMR-T-UNOPS-3</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Tuberculosis - Myanmar (01-Jan-2017-31-Dec-2017)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Myanmar, Tuberculosis, United Nations Office for Project Services (UNOPS)This program has the following goals: To End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035). The objectives of this program are: Objective 1: accelerate the decline in the prevalence of drug-sensitive and drug-resistant TB.  Objective 2: fully integrate TB prevention and care in Universal Health Coverage.  Objective 3: enhance the prevention of TB, particularly for high-risk populations</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<other-identifier ref="MMR-T-UNOPSP03" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2017-01-01" />
		<activity-date type="2" iso-date="2017-01-01" />
		<activity-date type="3" iso-date="2017-12-31" />
		<activity-date type="4" iso-date="2017-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Allan, NFAMBA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>allan.nfamba@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="MM" percentage="100">
			<narrative xml:lang="en">Myanmar</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12263" percentage="100">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="3bc50c5d-f260-4081-a831-f82a3f69c304">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-01-23" />
			<value currency="USD" value-date="2017-01-23">26091945.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f2907780-815d-4b57-99d4-d926b0f2dec1">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-12-18" />
			<value currency="USD" value-date="2018-12-18">-7583061.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7d33c9bf-dd6c-4e20-998c-36e3fc23003c">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-01-24" />
			<value currency="USD" value-date="2017-01-24">14228995.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7a44804f-5184-48d8-a905-e303ea5b8923">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-11-23" />
			<value currency="USD" value-date="2017-11-23">4229889.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d3754328-e2bc-4369-b919-15f5ef628a3e">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-01-18" />
			<value currency="USD" value-date="2018-01-18">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for MMR-T-UNOPSP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="1583" />
					<actual value="1670" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="3297" />
					<actual value="3197" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="28553" />
					<actual value="28256" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="13705" />
					<actual value="12904" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="72.20" />
					<actual value="54.10" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="72.20" />
					<actual value="56.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="50.00" />
					<actual value="5.20" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="50.00" />
					<actual value="7.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="3.00" />
					<actual value="1.80" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="3.00" />
					<actual value="1.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="97.50" />
					<actual value="98.10" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="97.50" />
					<actual value="97.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="90.00" />
					<actual value="87.70" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="90.00" />
					<actual value="87.20" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="1583" />
					<actual value="1394" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="3297" />
					<actual value="2666" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="90.00" />
					<actual value="88.80" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="90.00" />
					<actual value="88.80" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="8890" />
					<actual value="9100" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="18521" />
					<actual value="20032" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="95.00" />
					<actual value="96.90" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="95.00" />
					<actual value="97.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="94.00" />
					<actual value="94.80" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="94.00" />
					<actual value="96.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="74086" />
					<actual value="62555" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="154345" />
					<actual value="130414" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for MMR-T-UNOPSP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="70.00" />
					<actual value="80.23" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="342" />
					<actual value="266.43" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for MMR-T-UNOPSP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="44" />
					<actual value="47" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="359" />
					<actual value="361" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-MMR-T-UNOPS-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">TB control to reduce morbidity, mortality and transmission of TB in Myanmar - Myanmar (01-Jan-2013-31-Dec-2016)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Myanmar faces a major public health problem in Tuberculosis (TB).  The country is listed among the 22 high TB burden countries, among the 41 high TB and HIV burden countries and among the 27 high multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB burden countries. In 2007, an estimated 124,416 TB cases were notified in all forms, corresponding to a case notification rate of 265 cases per 100,000 population.  The program is implemented through a Dual Financing Track scheme and focuses on TB and high risk patients.  The proposal for this grant builds on the National TB Strategic Plan 2011 to 2015, and coordinated with both the National HIV/AIDS and Malaria proposals. The program aims to reduce the burden of TB by 2015 in line with the Millennium Development Goals (MDG) and Stop TB components of the new Stop TB Strategy.  The activities under current grant focus on engaging health providers through Public-Private Mix DOTS (Directly Observed Treatment, Short-Course), Public-Public Mix DOTS and introducing the International Standards of TB Care (ISTC).</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<other-identifier ref="MMR-T-UNOPSP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2013-01-01" />
		<activity-date type="2" iso-date="2013-01-01" />
		<activity-date type="3" iso-date="2016-12-31" />
		<activity-date type="4" iso-date="2016-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Allan, NFAMBA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>allan.nfamba@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="MM" percentage="100">
			<narrative xml:lang="en">Myanmar</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12263" percentage="100">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="b353e06a-a90a-4012-abe1-510ba155e471">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-08-26" />
			<value currency="USD" value-date="2015-08-26">20108037.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="84a99d2e-e83d-4df4-94a6-f2693eb737c2">
			<transaction-type code="2" />
			<transaction-date iso-date="2014-06-03" />
			<value currency="USD" value-date="2014-06-03">-3125393.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="33bb277b-ed00-428c-85ed-d7b0aaa04cea">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-04-01" />
			<value currency="USD" value-date="2016-04-01">-17572203.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7a610826-9867-4c4b-beef-22fdbd51f362">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-08-30" />
			<value currency="USD" value-date="2016-08-30">22873497.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e5606c2c-7b6f-4000-9731-f255d0ab5219">
			<transaction-type code="2" />
			<transaction-date iso-date="2014-01-16" />
			<value currency="USD" value-date="2014-01-16">16671223.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b4ad713c-7845-4c86-8910-706dbfe10c58">
			<transaction-type code="2" />
			<transaction-date iso-date="2014-06-03" />
			<value currency="USD" value-date="2014-06-03">24365400.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9e65ce8b-659c-46e6-bf49-80a09722777c">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-08-30" />
			<value currency="USD" value-date="2016-08-30">-12832352.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b3c1d016-f56c-49ed-9e8a-826ea9250277">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-04-01" />
			<value currency="USD" value-date="2016-04-01">24188641.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="320dfe31-ccd3-43f3-b236-8d260505d4c1">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-11-30" />
			<value currency="USD" value-date="2016-11-30">-3727000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cf42fcb7-e61e-4037-ac7b-1bb31ae350db">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-11-06" />
			<value currency="USD" value-date="2014-11-06">4837964.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5375371e-df9f-47a6-b334-3f11be9e892c">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-12-16" />
			<value currency="USD" value-date="2013-12-16">2961301.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5949bb74-d30c-4483-8f5d-5b0d577590b8">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-09-01" />
			<value currency="USD" value-date="2016-09-01">19146497.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9ef5050e-e458-4494-b62b-4d1696248ff4">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-12-16" />
			<value currency="USD" value-date="2014-12-16">11838521.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="55822120-5e17-44dd-a3f8-0e0c6669c6d4">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-04-04" />
			<value currency="USD" value-date="2016-04-04">11356289.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a1746a65-f0a8-4460-8231-8e5f9f15d137">
			<transaction-type code="3" />
			<transaction-date iso-date="2013-08-27" />
			<value currency="USD" value-date="2013-08-27">10584529.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5196e52f-54f9-4c9e-bf1e-777e8e67d0d2">
			<transaction-type code="3" />
			<transaction-date iso-date="2014-06-04" />
			<value currency="USD" value-date="2014-06-04">7688915.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ec1a6920-a257-47ac-bf1f-eeb380fabf8e">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-08-28" />
			<value currency="USD" value-date="2015-08-28">2535834.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for MMR-T-UNOPSP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
				</title>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="84.70" />
					<actual value="84.30" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="85.00" />
					<actual value="84.83" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="84.70" />
					<actual value="85.80" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="84.80" />
					<actual value="83.70" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="84.70" />
					<actual value="85.40" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="84.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="92.80" />
					<actual value="95.98" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="92.80" />
					<actual value="94.20" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="92.60" />
					<actual value="91.70" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="92.80" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="92.60" />
					<actual value="94.30" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="92.50" />
					<actual value="93.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative>
				</title>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="0.30" />
					<actual value="0.30" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="0.10" />
					<actual value="0.30" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="1.10" />
					<actual value="1.50" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="0.30" />
					<actual value="0.40" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="1.00" />
					<actual value="0.70" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="1.10" />
					<actual value="1.49" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="1600" />
					<actual value="1121" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="3200" />
					<actual value="2537" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="600" />
					<actual value="587" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="1747" />
					<actual value="1537" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="508" />
					<actual value="667" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="2000" />
					<actual value="979" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
				</title>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="2.50" />
					<actual value="2.59" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="2.30" />
					<actual value="2.30" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="2.50" />
					<actual value="2.60" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="2.20" />
					<actual value="2.10" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="2.20" />
					<actual value="2.20" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="2.30" />
					<actual value="2.20" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="153714" />
					<actual value="142170" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="76788" />
					<actual value="66593" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="81770" />
					<actual value="68623" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="159974" />
					<actual value="141944" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="171065" />
					<actual value="137404" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="82111" />
					<actual value="64799" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">MDR TB-other 1: Number of bacteriologically confirmed, drug resistant TB cases (RR-TB and/or MDR-TB) detected</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="3200" />
					<actual value="3213" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="400" />
					<actual value="881" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="1600" />
					<actual value="1463" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="2000" />
					<actual value="1359" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="1747" />
					<actual value="2276" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="600" />
					<actual value="738" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="53406" />
					<actual value="49780" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="49034" />
					<actual value="44737" />
				</period>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="25635" />
					<actual value="24986" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="50782" />
					<actual value="50119" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="24376" />
					<actual value="25620" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="25796" />
					<actual value="23989" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
				</title>
				<period>
					<period-start iso-date="2016-01-01" />
					<period-end iso-date="2016-06-30" />
					<target value="68.00" />
					<actual value="80.58" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="68.00" />
					<actual value="80.90" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-06-30" />
					<target value="45.30" />
					<actual value="60.90" />
				</period>
				<period>
					<period-start iso-date="2014-01-01" />
					<period-end iso-date="2014-06-30" />
					<target value="34.00" />
					<actual value="34.00" />
				</period>
				<period>
					<period-start iso-date="2014-07-01" />
					<period-end iso-date="2014-12-31" />
					<target value="34.00" />
					<actual value="39.50" />
				</period>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="9.80" />
					<actual value="8.50" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for MMR-T-UNOPSP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="44" />
					<actual value="54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="47" />
					<actual value="54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="46" />
					<actual value="54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="46" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="48" />
					<actual value="54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="47" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="44" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="48" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="47" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="48" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="44" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="46" />
					<actual value="49" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB prevalence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="506" />
					<actual value="466" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="460" />
					<actual value="466" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="480" />
					<actual value="466" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="460" />
					<actual value="466" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="480" />
					<actual value="457" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="460" />
					<actual value="457" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="506" />
					<actual value="457" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="460" />
					<actual value="457" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="359" />
					<actual value="373" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="366" />
					<actual value="388" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="381" />
					<actual value="388" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="359" />
					<actual value="388" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="366" />
					<actual value="373" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="381" />
					<actual value="373" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="373" />
					<actual value="388" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="373" />
					<actual value="373" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="373" />
					<actual value="365" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="359" />
					<actual value="365" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="381" />
					<actual value="365" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="366" />
					<actual value="365" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR TB prevalence among new TB patients: proportions of new TB cases with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2013-07-01" />
					<period-end iso-date="2013-12-31" />
					<target value="4.00" />
					<actual value="5.00" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for MMR-T-UNOPSP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate per 100,000 population- bacteriologically-confirmed TB, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="108" />
					<actual value="90.96" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="106" />
					<actual value="90.96" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="99" />
					<actual value="90.96" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="101" />
					<actual value="90.96" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="335" />
					<actual value="270.57" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="319" />
					<actual value="270.57" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="310" />
					<actual value="270.57" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="342" />
					<actual value="270.57" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB O-2b: Treatment success rate- bacteriologically confirmed: Percentage of bacteriologically confirmed TB cases successfully treated (cured plus treatment completed)</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="84.54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="84.54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="84.54" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="85.00" />
					<actual value="84.54" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB O-4: Treatment success rate- laboratory confirmed RR TB and/or MDR-TB: Percentage of bacteriologically-confirmed RR and/or MDR-TB cases successfully treated (cured plus completed treatment) among those enrolled on second-line anti-TB treatment during the year of assessment</narrative>
				</title>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="70.00" />
					<actual value="82.88" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="70.00" />
					<actual value="82.88" />
				</period>
				<period>
					<period-start iso-date="2016-07-01" />
					<period-end iso-date="2016-12-31" />
					<target value="70.00" />
					<actual value="82.88" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-MMR-T-UNOPS-6</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for Fight Against Tuberculosis - Myanmar (01-Jan-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Myanmar, Tuberculosis, United Nations Office for Project Services (UNOPS)This program has the following goals: End the TB epidemic in Myanmar (Fewer than 10 cases per 100,000 population by 2035) 50% reduction of TB incidence compared with 2015 baseline by 2025. The objectives of this program are: Expand TB services as part of Universal Health Coverage and strengthen partnerships.  Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations.  Achieve a faster decline in TB burden through an accelerated multisectoral TB response.  Expand TB services as part of Universal Health Coverage and strengthen partnerships.  Minimize TB transmission by intensifying efforts on prevention and reaching high-risk populations.  Achieve a faster decline in TB burden through an accelerated multisectoral TB response</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Office for Project Services</narrative>
		</participating-org>
		<other-identifier ref="MMR-T-UNOPSP06" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-01-01" />
		<activity-date type="2" iso-date="2024-01-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Allan, NFAMBA</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>allan.nfamba@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="MM" percentage="100">
			<narrative xml:lang="en">Myanmar</narrative>
		</recipient-country>
		<sector vocabulary="1" code="12110" percentage="26">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="6">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="68">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="25">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health financing systems -&gt; Public financial management (PFM) systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health financing systems -&gt; Routine financial management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="21">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="11">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Community care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-01-01">19259063.92</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-01-01">25711897.66</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-01-01">16010223.43</value>
		</budget>
		<transaction ref="b928b790-16a7-459e-9177-e844a9638ce0">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-07-03" />
			<value currency="USD" value-date="2025-07-03">-7822770.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="29e8bf38-e40d-487e-8c94-b73bbe15a06a">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-07-03" />
			<value currency="USD" value-date="2025-07-03">6750000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="efe603f2-1564-4964-aa59-94be597d3f26">
			<transaction-type code="2" />
			<transaction-date iso-date="2026-01-10" />
			<value currency="USD" value-date="2026-01-10">10572184.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4560405c-4dbf-4594-bfd8-1a6f705c2e96">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-01-15" />
			<value currency="USD" value-date="2024-01-15">30908983.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="edda94f0-6882-4eb6-a101-575b555e0e96">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-10-01" />
			<value currency="USD" value-date="2025-10-01">7847000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cf83e97a-64e6-4910-9ec9-acfa189459cd">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-10-01" />
			<value currency="USD" value-date="2025-10-01">-4200000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d4c9309a-e38d-4ccc-9e90-63ff7409bc2e">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-01-18" />
			<value currency="USD" value-date="2024-01-18">5879168.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1161460d-7144-40ee-a22b-ee6d8093f55e">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-01-13" />
			<value currency="USD" value-date="2026-01-13">1835000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d5482233-fb42-4d2a-91ab-e46de3c6f257">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-09-26" />
			<value currency="USD" value-date="2024-09-26">6514630.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ae0885e6-f7b6-46a4-b92a-a9f015a9eeea">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-07-25" />
			<value currency="USD" value-date="2024-07-25">1743000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="63dfe4a0-207e-4432-8f8b-e267f08cd331">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-07-08" />
			<value currency="USD" value-date="2025-07-08">2550000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aa6f4396-dbfb-4b0f-a9ba-03fe4feb9423">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-03-25" />
			<value currency="USD" value-date="2025-03-25">2437750.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="568f5d2e-588f-4eaf-be8c-71ba28e132cc">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-10-07" />
			<value currency="USD" value-date="2025-10-07">7847000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="83ce2019-be83-43ef-ae4c-781981d1bdbc">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-05-23" />
			<value currency="USD" value-date="2024-05-23">1694890.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f04d609d-0b49-4609-9171-45e305b740e7">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-06-27" />
			<value currency="USD" value-date="2024-06-27">3814607.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d36da9a3-aa7a-4cc7-a7cb-ca725f16fc91">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-01-07" />
			<value currency="USD" value-date="2025-01-07">1002168.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to MMR-T-UNOPSP06.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Office for Project Services (UNOPS)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/MMR-T-UNOPS" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for MMR-T-UNOPSP06</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="88.00" />
					<actual value="105.98" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="74.99" />
					<actual value="72.66" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="468" />
					<actual value="214" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="16.00" />
					<actual value="10.94" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="80.00" />
					<actual value="77.99" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="90.00" />
					<actual value="87.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="90.00" />
					<actual value="87.99" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="2066" />
					<actual value="1171" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people in contact with TB patients who began preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="5827" />
					<actual value="4271" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="24.50" />
					<actual value="30.14" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people with RR-TB/MDR-TB who did not start treatment and/or started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="14.23" />
					<actual value="13.34" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="90.00" />
					<actual value="96.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="66882" />
					<actual value="54761" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
				</title>
				<period>
					<period-start iso-date="2024-01-01" />
					<period-end iso-date="2024-06-30" />
					<target value="65.00" />
					<actual value="60.15" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>